Target intelligence / Profile preview

Zinc metalloenzyme

Molecular classification
Enzyme
01

Overview

Zinc metalloenzymes are a diverse superfamily of enzymes that require Zn(II) ions for catalytic or structural roles, found in all six EC enzyme classes including hydrolases like carboxypeptidase and carbonic anhydrase, oxidoreductases like alcohol dehydrogenase, and lyases like aldolase.[1][3][5] The Zn center typically adopts distorted tetrahedral geometry coordinated by His, Cys, Asp, Glu, or water, enabling Lewis acid activation of substrates such as water for nucleophilic attack in hydrolysis or CO2 hydration.[1][3] These enzymes participate in critical processes like respiration (CO2 transport via carbonic anhydrase), protein degradation (carboxypeptidases), alcohol metabolism, DNA synthesis, cell proliferation, and apoptosis regulation.[2][3] Dysregulation links them to diseases: overexpressed carbonic anhydrases and matrix metalloproteinases (MMPs) in tumors promote invasion and acidosis, while histone deacetylases (HDACs) drive oncogenesis.[4] Therapeutics target the active site Zn, with inhibitors like acetazolamide for glaucoma (CA) or doxycycline for cancer metastasis (MMPs), though broad inhibition risks toxicity from disrupting Zn homeostasis.[1][2][4]

Other names
Zinc-containing enzymeZn enzymeZn metalloprotease (for subset)Zn hydrolase (for subset)
02

Mechanism of action

Inhibition of catalytic Zn-bound water activation (e.g., carbonic anhydrase); Chelation or displacement of active site Zn (e.g., matrix metalloproteinases); Hydroxamic acid coordination to Zn in HDACs; Displacement of Zn ligands like His/Cys/Asp/Glu

03

Biological functions

HydrolysisCarbon dioxide transportOxidoreductionDNA synthesisCell proliferationApoptosis regulationAntioxidant defenseSignal transduction
04

Disease associations

CancerInflammationNeurodegenerative diseaseInfection
05

Safety considerations

Zn chelation leading to enzyme dysfunctionOff-target inhibition of essential Zn enzymes (e.g., carboxypeptidase)Excess Zn release inducing oxidative stressMitochondrial dysfunction from HDAC/MMP inhibition
06

Interacting drugs

Acetazolamide (carbonic anhydrase inhibitor)

5 more in the full profile.

Beyond the preview

Go deeper on Zinc metalloenzyme.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc metalloenzyme.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call